Cleared Traditional

K023380 - T-WAVE ALTERMANS (TWA) ALGORITHM OPTION

K023380 is an FDA 510(k) clearance for T-WAVE ALTERMANS (TWA) ALGORITHM OPTION, manufactured by General Electric Medical Systems Information Techn. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 56-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
56d
Days
Class 2
Risk

K023380 is an FDA 510(k) clearance for the T-WAVE ALTERMANS (TWA) ALGORITHM OPTION. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by General Electric Medical Systems Information Techn (Milwaukee, US). The FDA issued a Cleared decision on December 3, 2002 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K023380

510(k) Number K023380 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 2002
Decision Date December 03, 2002
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 440
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K023380.
CHEETAH I.V.D.S., MODEL 2002P
K023370 · Cheetah Medical, Inc. · Dec 2002
PROSOLV CARDIVASCULAR VIEWER
K023112 · Problem Solving Concepts, Inc. · Dec 2002
NEWCOR
K020440 · Siemens Medical Systems, Inc. · Dec 2002
RADIANALYZER, MODEL 12710
K022188 · Radi Medical Systems AB · Oct 2002
QIVA
K021495 · Pie Medical Imaging BV · Oct 2002
CARDIS
K023015 · Schwarzer GmbH · Sep 2002